文献速递垂体与肾上腺疾病

GC-MS/MS揭示肾上腺意外瘤亚临床高皮质醇症的复杂类固醇指纹

Novel GC-MS/MS Technique Reveals a Complex Steroid Fingerprint of Subclinical Hypercortisolism in Adrenal Incidentalomas.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

无功能11例、亚临床高皮质醇症41例)及26名年龄性别匹配对照,用GC-MS/MS检测83种类固醇。亚临床高皮质醇症患者中10种类固醇显著降低,包括DHEAS等肾上腺雄激素及其代谢物。GC-MS/MS可揭示常规方法未发现的类固醇代谢改变。

要点

  • 亚临床高皮质醇症与肾上腺雄激素及其代谢物水平降低相关。
  • DHEAS是区分亚临床高皮质醇症最具鉴别力的指标。
  • GC-MS/MS可检测常规方法未覆盖的类固醇代谢变化。

核心结论

  • 亚临床高皮质醇症与肾上腺雄激素、其代谢物及孕烯醇酮代谢物水平降低相关。
  • GC-MS/MS是检测肾上腺意外瘤中亚临床高皮质醇症相关类固醇代谢改变的有力工具。

研究设计与样本

  • 横断面研究,在三级住院门诊开展。
  • 用气相色谱-串联质谱(GC-MS/MS)检测83种血清类固醇,并行1 mg地塞米松试验前后、ACTH、午夜血清皮质醇及24小时尿游离皮质醇检测。

主要发现

  • 83种类固醇中,亚临床高皮质醇症患者有10种显著降低,包括硫酸脱氢表雄酮(DHEAS)、雄酮硫酸盐、表雄酮硫酸盐、雄烯二醇硫酸盐、共轭5α-雄烷-3β,17β-二醇及共轭5α-雄烷-3α,17β-二醇。
  • 上述发现在单侧、双侧、男性和女性亚组中分别分析时均存在。
  • 比较常规临床方法与GC-MS/MS检测的类固醇,鉴别力最强的是DHEAS,其次为午夜血清皮质醇、表雄酮硫酸盐、雄酮硫酸盐、ACTH和16α-羟基孕烯醇酮。

关键数值与推荐

  • 亚临床高皮质醇症患者中10种血清类固醇显著降低,包括DHEAS等肾上腺雄激素及代谢物。
  • 鉴别力排序:DHEAS最强,其次为午夜血清皮质醇、表雄酮硫酸盐、雄酮硫酸盐、ACTH、16α-羟基孕烯醇酮。

临床怎么用

  • 对肾上腺意外瘤患者评估亚临床高皮质醇症时,可关注DHEAS等肾上腺雄激素及其代谢物的降低。
  • GC-MS/MS可提供常规方法未覆盖的类固醇代谢信息,有助于识别亚临床高皮质醇症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Improvement of imaging methods has led to more incidental adrenal tumor findings, especially adenomas. Routine hormonal evaluation uses only a few steroids to evaluate possible hormonal hypersecretion of these adenomas, but a wide spectrum of serum steroid hormone changes has not been published. OBJECTIVE: To measure the serum levels of 83 steroids from patients with unilateral and bilateral adrenal incidentalomas to uncover full steroid profile changes in patients with subclinical hypercortisolism (SH). DESIGN: Cross-sectional study. SETTING: The study was conducted at a tertiary inpatient clinic. PATIENTS: Fifty-two patients with adrenal incidentalomas (unilateral, n = 29; bilateral, n = 23), including nonfunctioning (n = 11) vs SH (n = 41), and 26 age- and sex-matched controls from the general population were included. MAIN OUTCOME MEASURES: Eighty-three serum steroids were measured by gas chromatography-tandem mass spectrometry (GC-MS/MS) before and after 1 mg dexamethasone, ACTH, midnight serum cortisol, and urinary free cortisol/24 hour. RESULTS: Of 83 measured steroids, 10 were significantly decreased in patients with SH, including dehydroepiandrosterone sulfate (DHEAS), androsterone sulfate, epiandrosterone sulfate, androstenediol sulfate, conjugated 5α-androstane-3β,17β-diol, and conjugated 5α-androstane-3α,17β-diol. This finding was observed even when unilateral, bilateral, male, and female subgroups were analyzed separately. When we compared routine clinical methods and GC-MS/MS‒measured steroids, the most discriminatory was DHEAS followed by midnight serum cortisol, epiandrosterone sulfate, androsterone sulfate, ACTH, and 16α-hydroxypregnenolone. CONCLUSIONS: SH was associated with decreased levels of adrenal androgens, their metabolites, and pregnenolone metabolite. GC-MS/MS is a powerful tool for measuring serum levels of these undescribed changes in steroid metabolism, which are characteristic of SH in adrenal incidentalomas.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Hána V, Ježková J, Kosák M, et al. Novel GC-MS/MS Technique Reveals a Complex Steroid Fingerprint of Subclinical Hypercortisolism in Adrenal Incidentalomas. J Clin Endocrinol Metab. 2019. PMID: 30896752. doi:10.1210/jc.2018-01926

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。